"당장은 버틴다" 제약업계, 의약품 수급불안 장기화 '예의주시'

South Korea's pharmaceutical and medical supply sectors face critical shortages as the Middle East conflict triggers naphta supply disruptions, affecting essential items like IV bags and syringes. While the government has implemented emergency measures including raw material priority allocation and regulatory relief, industry experts caution these are temporary fixes dependent on sustained government support and supply chain resilience. Authorities are simultaneously enforcing strict penalties against market manipulation—including fines up to 20% of sales for price-fixing—to prevent exploitation of the supply crisis.